Lincoln Financial (NYSE: LNC) today reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth quarter net income available to ...
Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...
Uganda launched a vaccination campaign on Monday to stop the spread of the Sudan Ebola virus disease (SVD), which has so far killed one health worker ...